Alison M. Weppler

305 Grattan St
Melbourne, VIC 3000, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Erratum: Clinical Effectiveness and Cost-Effectiveness of Multigene Panel Sequencing in Advanced Melanoma: A Population-Level Real-World Target Trial Emulation.

Erratum: Clinical Effectiveness and Cost-Effectiveness of Multigene Panel Sequencing in Advanced Melanoma: A Population-Level Real-World Target Trial Emulation.

Journal: JCO precision oncology

Published: April 23, 2025

Patient and population impacts of multigene panel and pembrolizumab coverage in metastatic melanoma.

Patient and population impacts of multigene panel and pembrolizumab coverage in metastatic melanoma.

Journal: Journal of the National Cancer Institute

Published: March 24, 2025

Patient and population impacts of multi-gene panel and pembrolizumab coverage in metastatic melanoma.

Patient and population impacts of multi-gene panel and pembrolizumab coverage in metastatic melanoma.

Journal: Journal of the National Cancer Institute

Published: March 24, 2025

Clinical Effectiveness and Cost-Effectiveness of Multigene Panel Sequencing in Advanced Melanoma: A Population-Level Real-World Target Trial Emulation.

Clinical Effectiveness and Cost-Effectiveness of Multigene Panel Sequencing in Advanced Melanoma: A Population-Level Real-World Target Trial Emulation.

Journal: JCO precision oncology

Published: February 21, 2025

Novel endoscopic scoring system for immune mediated colitis: a multicenter retrospective study of 674 patients.

Novel endoscopic scoring system for immune mediated colitis: a multicenter retrospective study of 674 patients.

Journal: Gastrointestinal endoscopy

Published: October 10, 2023

Imaging for assessment of cancer treatment response to immune checkpoint inhibitors can be complementary in identifying hypophysitis.

Imaging for assessment of cancer treatment response to immune checkpoint inhibitors can be complementary in identifying hypophysitis.

Journal: Frontiers in endocrinology

Published: September 17, 2023

FDG PET/CT Prognostic Markers in Patients with Advanced Melanoma Treated with Ipilimumab and Nivolumab.

FDG PET/CT Prognostic Markers in Patients with Advanced Melanoma Treated with Ipilimumab and Nivolumab.

Journal: Radiology

Published: February 28, 2023

Durability of response to immune checkpoint inhibitors in metastatic Merkel cell carcinoma after treatment cessation.

Durability of response to immune checkpoint inhibitors in metastatic Merkel cell carcinoma after treatment cessation.

Journal: European journal of cancer (Oxford, England : 1990)

Published: October 22, 2022

Tissue-resident memory T cells from a metastatic vaginal melanoma patient are tumor-responsive T cells and increase after anti-PD-1 treatment.

Tissue-resident memory T cells from a metastatic vaginal melanoma patient are tumor-responsive T cells and increase after anti-PD-1 treatment.

Journal: Journal for immunotherapy of cancer

Published: April 05, 2022

Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition - A Descriptive Observational Retrospective Multicenter Analysis.

Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition - A Descriptive Observational Retrospective Multicenter Analysis.

Journal: Frontiers in oncology

Published: August 27, 2021

Melanoma brain metastases that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES).

Melanoma brain metastases that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES).

Journal: Journal for immunotherapy of cancer

Published: August 20, 2021

Combination anti-PD1 and ipilimumab therapy in patients with advanced melanoma and pre-existing autoimmune disorders.

Combination anti-PD1 and ipilimumab therapy in patients with advanced melanoma and pre-existing autoimmune disorders.

Journal: Journal for immunotherapy of cancer

Published: March 14, 2021

Showing 1-12 of 21

Last Updated: 09/26/2026